The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
The health effects of dietary unsaturated fatty acids
Open accessAbstract
Summary Introduction What are unsaturated fatty acids? Unsaturated fatty acids in the UK diet Unsaturated fatty acids in health and disease Unsaturated fatty acids and public health Conclusions Acknowledgements References Appendix 1 Summary Fat provides energy; indeed it is the most energy dense of all the macronutrients, with 1 g providing 37 kJ (9 kcal). However, the constituent parts of fat, fatty acids, are required by the body for many other functions than simply as an energy source, and there is an increasing awareness of the potential health benefits of specific types of fatty acids. Fatty acids are long hydrocarbon chains, with a methyl group at one end (the omega or n‐end) and an acid group at the other. Unsaturated fatty acids are hydrocarbon chains containing at least one carbon–carbon double bond; monounsaturated fatty acids contain one double bond, and polyunsaturated fatty acids (PUFAs) contain many double bonds. The position of the double bond relative to the omega end determines whether a PUFA is an n‐3 (omega 3) or an n‐6 (omega 6) fatty acid. Most fatty acids can be synthesised in the body, but humans lack the enzymes required to produce two fatty acids. These are called the essential fatty acids and must be acquired from the diet. In humans, the essential fatty acids are the n‐3 PUFA α‐linolenic acid and the n‐6 PUFA linoleic acid. Although humans can elongate dietary α‐linolenic acid to the long chain n‐3 PUFAs eicosapentaenoic acid and docosahexaenoic acid, the rate of synthesis may not be sufficient to meet requirements, and it is, therefore, recommended that good sources of these fatty acids, namely, oil‐rich fish, are also included in the diet. Fat is found in most food groups, and foods containing fat generally provide a range of different fatty acids, both saturated and unsaturated. In the UK, the major dietary sources of unsaturated fatty acids include meat & meat products, cereals & cereal products and potatoes & savoury snacks; primarily as a result of the vegetable oil used in processing. Recommended intakes of both total fat and the different types of fatty acids have been set for the UK population, and it is possible to monitor fat intake from the data collected in nationwide dietary surveys. As a population, we are not currently meeting these recommendations, so there is still scope for dietary change. In Western diets, n‐6 fatty acids are the predominant PUFAs, and this is in line with current dietary advice to consume a minimum of 1% energy as n‐6 PUFAs and 0.2% energy as n‐3 PUFAs. The balance of n‐3 and n‐6 PUFAs in Western diets has changed substantially over the last 100 years or so, and as the two families of PUFAs share a common metabolic pathway, concerns have been raised that this might be detrimental to health; what is becoming increasingly clear is that both n‐3 and n‐6 PUFAs have independent health effects in the body, and as intakes of the n‐6 PUFAs are within the guidelines for a healthy diet, concerns about the n‐6 to n‐3 ratio are driven by low intakes of n‐3 rather than high intakes of n‐6. Currently in adults n‐6 PUFAs contribute to 5.3% energy. Detecting associations between components of the diet and risk of various diseases is notoriously complex and in many cases, the evidence is still accumulating. Cardiovascular disease, characterised by hardening and narrowing of blood vessels and/or the development of blood clots, is one of the leading causes of mortality and morbidity worldwide. The type and total amount of dietary fat has a clear part to play in affecting an individual’s disease risk, yet the precise mechanisms by which unsaturated fatty acids reduce cardiovascular disease risk are still unclear. A number of mechanisms whereby dietary fatty acids could influence the progression of cardiovascular disease and its risk factors have been identified. These include effects on blood lipid concentrations, blood pressure, inflammatory response, arrhythmia and endothelial function, along with many other effects, both known and as yet undefined. A well‐established risk factor for cardiovascular disease is an elevated plasma low density lipoprotein (LDL) cholesterol concentration. Replacing saturated fatty acids with either monounsaturated fatty acids or n‐6 PUFAs reduces LDL (the ‘bad’) cholesterol, and so reduces the risk of developing the disease. Unsaturated fatty acids, such as linoleic acid or monounsaturated fatty acids, also slightly raise high density lipoprotein (HDL) (the ‘good’) cholesterol, which assists in the removal of triacylglycerols from the bloodstream. Interest in the health effects of the long chain n‐3 PUFAs found in fish oils is also increasing. There is strong supportive, but not yet conclusive, evidence that these fatty acids protect against fatal heart disease. On the basis of this conclusion, in 2004 the Scientific Advisory Committee on Nutrition advised the UK government to adopt the population‐wide dietary recommendation to eat at least two portions of fish per week, of which one should be oil‐rich, equivalent to 0.45 g of the long chain n‐3 PUFAs per day. In recent years, the potential health benefits of α‐linolenic acid has attracted attention, and evidence is mounting on the role that this n‐3 fatty acid may play in preventing the progression of cardiovascular disease, although it is currently unclear what, if any, association exists. Brain cells are especially rich in certain long chain PUFAs. This has led to the suggestion that dietary status of these long chain fatty acids might influence cognitive function and behaviour. Research in this field is still in its early stages, but there is a small amount of evidence to suggest improvements in cognitive function following fatty acid supplementation. In contrast, it is well established that pregnant women must have an adequate supply of the long chain n‐3 PUFAs before and throughout pregnancy and lactation to support normal growth, neurological development and cognitive function of the baby. As n‐6 PUFAs are more abundant in the diet, achieving an adequate intake is less problematic. However, this is not the case for the n‐3 PUFAs; increasing fish consumption beyond two servings of oil‐rich fish per week or relying on fish oil supplementation is not appropriate during pregnancy due to the potential problems associated with heavy metal contamination of fish, or the high vitamin A level in some fish oil supplements. Unsaturated fatty acids have also been associated with a number of other diseases and although the evidence is by no means conclusive, it is an area that is attracting a huge amount of interest. Dietary fat affects a number of different metabolic pathways, including those involved with glycaemic control, so the types and amounts of dietary fat may have a role to play in the management of type 2 diabetes. Unsaturated fatty acids may also be associated with a reduced risk of developing certain cancers, including cancers of the colon, breast and prostate, although currently the level of evidence is not deemed sufficient by authoritative bodies, such as the World Cancer Research Fund, World Health Organization and the Department of Health, to make any specific dietary recommendations. There are a number of inflammatory conditions, such as asthma, Crohn’s disease and arthritis, which could potentially be alleviated by dietary modification. The fatty acid composition of cell membranes can be altered by consumption of both n‐3 and n‐6 PUFAs, and this can result in reduced inflammatory activity. However, whether this effect brings about a significant reduction in clinical symptoms is still unclear. It is also important to note that there are concerns that the beneficial effects on certain disease outcomes are only observed with very high intakes of unsaturated fatty acids, which could realistically only be achievable by supplementation. Few nutritionists would be comfortable recommending supplement use as the only alternative to fish, as this can be expensive and goes against the idea that all the nutrients that our bodies require can be obtained from the food that we eat if the right choices are made. Unsaturated fatty acids are now a nutritional hot topic, and their presence in foods has attracted both public and industrial interest. There is currently no specific legislation to control the use of health claims relating to the fatty acid content of foods. However, a European Union (EU) Directive is expected imminently which will formally set down the criteria that a product will have to meet in order to make any nutrition or health claim. With regards to the current recommendations, those for the UK are in line with those around the world. However, as a population, we need to increase our consumption of long chain n‐3 PUFAs and decrease intake of saturated fatty acids. To facilitate this, food technologists are looking at ways in which the fatty acid profile of a food can be modified in order to bring dietary improvements without requiring a major change in dietary habits. However, public health messages surrounding the optimum intakes of fatty acids must be clear and consistent to ensure that a favourable change in the fatty acid profile of the UK diet occurs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Specific versus non-specific effects of dietary fat on carcinogenesis
Guthrie, N., & Carroll, K. K. (1999) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00006-5 · Cited by 59
Essential fatty acids and their role in the treatment of impulsivity disorders
Hallahan, B. P., & Garland, M. R. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.03.006 · Cited by 53
Frayn, K. N., & Stanner, S. A. (2005) · Cited by 51
Does diet have a role in the aetiology of rheumatoid arthritis?
Pattison, D. J., Symmons, D. P. M., & Young, A. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2003319 · Cited by 51
Nicolosi, R. J., Woolfrey, B., Wilson, T. A., Scollin, P., Handelman, G. J., & Fisher, R. A. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.04.001 · Cited by 51
Modern fat technology: what is the potential for heart health?
Upritchard, J., Zeelenberg, M., Huizinga, H., Verschuren, P., & Trautwein, E. (2005) · Proceedings of the Nutrition Society · doi:10.1079/pns2005446 · Cited by 50
Biomarkers of fatty acid exposure and breast cancer risk
Kohlmeier, L. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.6.1548s · Cited by 49
Liepa, G. U. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021003320 · Cited by 46
Nutrition and diet for healthy lifestyles in Europe: the ‘Eurodiet’ Project
Kafatos, A., & Codrington, C. (1999) · Public Health Nutrition · doi:10.1017/s1368980099000439 · Cited by 43
Lipid treatment of inflammatory bowel disease
Endres, S., Lorenz, R. L., & Loeschke, K. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199903000-00004 · Cited by 41
Hansen, J., Grimsgaard, S., Nordøy, A., & Bønaa, K. H. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(99)00223-6 · Cited by 36
Dietary monounsaturated fatty acids and haemostasis
Kelly, C. N. M., Smith, R. D., & Williams, C. M. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns200087 · Cited by 36
Diet and ischaemic heart disease in the Caerphilly Study.
FEHILY, A. M., YARNELL, J. W. G., & Butland, B. K. (1987) · PubMed · Cited by 35
Fish consumption and risk of stroke in men
He, K., Rimm, E. B., & Merchant, A. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00047-3 · Cited by 35
Mortensen, A., Hansen, B. F., Hansen, J. F., Frandsen, H. L., Bartnikowska, E., Andersen, P. S., & Bertelsen, L. S. (1998) · British Journal Of Nutrition · doi:10.1017/s0007114598001664 · Cited by 33
Graham, I. A., Cirpus, P., Rein, D., & Napier, J. A. (2004) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2004.00440.x · Cited by 33
Nicolosi, R. J., Wilson, T. A., Handelman, G. J., Foxall, T., Keaney, J. F., & Vita, J. A. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00202-4 · Cited by 30
Molecular Basis Of Human Nutrition
Sanders, T. A. B., & Emery, P. W. (2003) · CRC Press eBooks · doi:10.1201/9780367806323 · Cited by 26
(2000) · Nutrition Bulletin · doi:10.1046/j.1467-3010.2000.00013.x · Cited by 26
LIPGENE: an integrated approach to tackling the metabolic syndrome.
Buttriss, J. L., & Nugent, A. P. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2005441 · Cited by 25
Coronary Heart Disease and the Composition of Adipose Tissue Taken At Biopsy
Thomas, L. H., Olpin, S. O., Scott, R. G., & Wilkins, M. P. (1987) · Human Nutrition Food Sciences and Nutrition · doi:10.1080/09528954.1987.11904112 · Cited by 24
Walker, C. L. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.699.26 · Cited by 23
Respiratory symptoms in Greenlanders living in Greenland and Denmark: a population-based study
Backer, V., Nepper-Christensen, S., Porsbjerg, C. M., von Linstow, M., & Reersted, P. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61450-0 · Cited by 20
Low dietary intake of linoleic acid predisposes to myocardial infarction
Simpson, H., Barker, K., Carter, R., Cassels, E., & Mann, J. (1982) · British medical journal · doi:10.1136/bmj.285.6343.683 · Cited by 18
Hamazaki, T., Sawazaki, S., Asaoka, E., Itomura, M., Mizushima, Y., Yazawa, K., Kuwamori, T., & Kobayashi, M. (1996) · Journal of Nutrition · doi:10.1093/jn/126.11.2784 · Cited by 17
(1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90133-2 · Cited by 11
LIPGENE: an EU project to tackle the metabolic syndrome
Nugent, A. P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.10.024 · Cited by 8
Developing polyunsaturated fatty acids as functional ingredients
Jacobsen, C. (2004) · Elsevier eBooks · doi:10.1533/9781855739499.3.307 · Cited by 8
Frayn, K. N., & Stanner, S. A. (2005) · doi:10.1002/9780470774663.ch10 · Cited by 8
New marine sources of polyunsaturated fatty acids (PUFAs)
Sanders, T. A. B., & Theobald, H. E. (2006) · Elsevier eBooks · doi:10.1533/9781845691073.3.454 · Cited by 3
Self-citation
Cited by
Lordan, S., Ross, R. P., & Stanton, C. (2011) · Marine Drugs · doi:10.3390/md9061056 · Cited by 748
Flaxseed—a potential functional food source
Kajla, P., Sharma, A., & Sood, D. R. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1293-y · Cited by 536
Dietary Polyunsaturated Fatty Acids (PUFAs): Uses and Potential Health Benefits
Kapoor, B., Kapoor, D., Gautam, S., Singh, R., & Bhardwaj, S. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00363-3 · Cited by 418
Mariamenatu, A. H., & Abdu, E. M. (2021) · Journal of Lipids · doi:10.1155/2021/8848161 · Cited by 346
Woods, V. B., & Fearon, A. M. (2009) · Livestock Science · doi:10.1016/j.livsci.2009.07.002 · Cited by 338
Metadata
- Authors
- Lunn, J., & Theobald, H. E.
- Venue
- Nutrition Bulletin
- Publisher
- Wiley
- Published
- 2006-08-25
- Volume
- 31
- Issue
- 3
- Pages
- 178-224
- ISSN
- 1467-3010 (ISSN-L)
- 1471-9827
- OpenAlex
- W2094336960
- Cited by
- 401
- References
- 230
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.